[go: up one dir, main page]

ES2086521T3 - Proteina hibrida laci-factor x. - Google Patents

Proteina hibrida laci-factor x.

Info

Publication number
ES2086521T3
ES2086521T3 ES91870008T ES91870008T ES2086521T3 ES 2086521 T3 ES2086521 T3 ES 2086521T3 ES 91870008 T ES91870008 T ES 91870008T ES 91870008 T ES91870008 T ES 91870008T ES 2086521 T3 ES2086521 T3 ES 2086521T3
Authority
ES
Spain
Prior art keywords
laci
factor
hybrid protein
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91870008T
Other languages
English (en)
Inventor
Thomas James Girard
George John Broze Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Application granted granted Critical
Publication of ES2086521T3 publication Critical patent/ES2086521T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UNA SIMPLE CADENA HIBRIDA DE INHIBICION DE LA COAGULACION DE LA SANGRE HA SIDO DESCUBIERTA, LA CUAL TIENE UNA SECUENCIA AMINO ACIDA COMPUESTA DE DOS SUBSECUENCIAS CORRESPONDIENTES A UNA CADENA LIGERA DEL FACTOR X Y QUE PRIMERO NEUTRALIZO KUNITZ CON EL LACI.
ES91870008T 1990-01-25 1991-01-21 Proteina hibrida laci-factor x. Expired - Lifetime ES2086521T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47028990A 1990-01-25 1990-01-25

Publications (1)

Publication Number Publication Date
ES2086521T3 true ES2086521T3 (es) 1996-07-01

Family

ID=23866994

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91870008T Expired - Lifetime ES2086521T3 (es) 1990-01-25 1991-01-21 Proteina hibrida laci-factor x.

Country Status (8)

Country Link
EP (1) EP0439442B1 (es)
JP (1) JP2560150B2 (es)
AT (1) ATE135044T1 (es)
CA (1) CA2034881C (es)
DE (1) DE69117545T2 (es)
DK (1) DK0439442T3 (es)
ES (1) ES2086521T3 (es)
GR (1) GR3019877T3 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0473564T3 (da) * 1990-08-27 1996-04-15 Monsanto Co Antikoagulant kombination af LACI og sulfatiserede polysaccharider
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
EP0671944A4 (en) * 1992-09-25 1996-07-24 Corvas Int Inc TISSUE VIA-THROMBOPLASTIN FACTOR COMPLEX INHIBITORS DERIVED FROM A BOVINE PANCREATIC TRYPSIN INHIBITOR.
CA2202351A1 (en) * 1994-10-18 1996-04-25 George Phillip Vlasuk Nematode-extracted serine protease inhibitors and anticoagulant proteins
US5872098A (en) * 1995-06-05 1999-02-16 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5945275A (en) * 1994-10-18 1999-08-31 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5863894A (en) * 1995-06-05 1999-01-26 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5866542A (en) * 1994-10-18 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5866543A (en) * 1995-06-05 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
ES2276396T3 (es) 1994-10-18 2007-06-16 Dendreon Corporation Proteinas anticoagulantes e inhibidores de la serina proteasa extraidos de nematodos.
US5772629A (en) * 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
US5736364A (en) * 1995-12-04 1998-04-07 Genentech, Inc. Factor viia inhibitors
AU1023497A (en) * 1995-12-01 1997-06-27 Genentech Inc. Tissue factor - kunitz domain fusion proteins as factor viia inhibitors
ES2263174T3 (es) 1996-03-11 2006-12-01 Bayer Corporation Bikunina humana.
EP0927764B1 (de) * 1997-12-03 2004-05-26 Boehringer Mannheim Gmbh Chimäre Serinproteasen
US6159722A (en) 1997-12-03 2000-12-12 Boehringer Mannheim Gmbh Chimeric serine proteases
EP2067488A1 (en) * 2000-04-12 2009-06-10 Human Genome Sciences, Inc. Albumin fusion proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co cDNA of human tissue factor inhibitor

Also Published As

Publication number Publication date
DE69117545T2 (de) 1996-10-31
GR3019877T3 (en) 1996-08-31
ATE135044T1 (de) 1996-03-15
DK0439442T3 (da) 1996-07-08
CA2034881C (en) 2001-05-29
JPH04211000A (ja) 1992-08-03
EP0439442A3 (en) 1992-05-27
EP0439442A2 (en) 1991-07-31
EP0439442B1 (en) 1996-03-06
CA2034881A1 (en) 1991-07-26
JP2560150B2 (ja) 1996-12-04
DE69117545D1 (de) 1996-04-11

Similar Documents

Publication Publication Date Title
ES2086521T3 (es) Proteina hibrida laci-factor x.
ATE200783T1 (de) Neuartige peptidderivate
DK0625912T3 (da) Behandling af inflammatorisk tarmsygdom
DE122006000010I2 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3-Benzazepin-2-ones, verwendbar in derBehandlung von kardiovaskularen Krankheiten
NO883270L (no) Dna-klon for human vevfaktorinhibitor.
ES551820A0 (es) Un procedimiento para la fabricacion de derivados peptidicos inhibidores de la renina y de las proteasas acidas
ATE206877T1 (de) Fluorierte kasein-mizellen
ES2072490T3 (es) Procedimiento para la pasteurizacion de la proteina tisular pp4.
MX9102086A (es) Complejos que contienen acidos s(+) fenilalcanos y amino-azucares
UA15913A (uk) Засіб для лікуваhhя запальhих захворюваhь стравоходу та запальhих виразкових захворювань шлуhково-кишкового тракту
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
FI925696A7 (fi) Hirudiinin aminohapposekvenssiin perustuvia trombiininestäjiä
DK226889A (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
MX9102088A (es) Complejos que contienen acidos s(+) fenilalcanos y alfa-aminoacidos
DE3769910D1 (de) Verwendung von n, n'-bis-l-aminosaeure-l-cystinpeptiden in aminosaeure-praeparaten fuer orale und parenterale ernaehrung.
PT920632E (pt) Metodos para deteccao de doencas auto-imunes
ATE107165T1 (de) Verwendung von macrolactonen als antiallergica.
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
DK53290A (da) Syntetiske gaer-leader-peptider
NO962701D0 (no) Lyslist for retningsanvisning i form av vandrende lys
NO951048D0 (no) Lys gren
SE9402855L (sv) Trappstegsmatare

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 439442

Country of ref document: ES